Potential treatment of calciphylaxis with vitamin K(2): Comment on the article by Jacobs-Kosmin and DeHoratius.
Robert
R
Levy
D002115:Calciphylaxis / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D002135:Calcium-Binding Proteins / Q000378:metabolism; D016326:Extracellular Matrix Proteins / Q000378:metabolism; D006801:Humans; D053245:RANK Ligand / Q000378:metabolism; D024482:Vitamin K 2 / Q000378:metabolism / Q000627:therapeutic use*; D014813:Vitamin K Deficiency / Q000150:complications; D000097568:Matrix Gla Protein
D002135:Calcium-Binding Proteins; D016326:Extracellular Matrix Proteins; D053245:RANK Ligand; D024482:Vitamin K 2; D000097568:Matrix Gla Protein; C505688:TNFSF11 protein, human